Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
ACS Chemical Neuroscience
|
November 27, 2020
Viral Infection-Induced Gut Dysbiosis, Neuroinflammation, and α-Synuclein Aggregation: Updates and Perspectives on COVID-19 and Neurodegenerative Disorders
Cristian Follmer
Phytochemistry
|
August 21, 2007
Insights into the role and structure of plant ureases
Cristian Follmer
Expert Review of Neurotherapeutics
|
May 24, 2014
Monoamine oxidase and α-synuclein as targets in Parkinson's disease therapy
Cristian Follmer
Archives of Biochemistry and Biophysics
|
February 1, 2005
Effect of chemical modification of histidines on the copper-induced oligomerization of jack bean urease (EC 3.5.1.5)
Cristian Follmer, Célia R Carlini
ACS Chemical Neuroscience
|
October 20, 2020
<i>In Vitro</i> Protective Action of Monomeric and Fibrillar α-Synuclein on Neuronal Cells Exposed to the Dopaminergic Toxins Salsolinol and DOPAL
Phelippe Carmo-Gonçalves, Luciana Romão, Cristian Follmer
Bioorganic & Medicinal Chemistry Letters
|
May 20, 2014
Pitfalls associated with the use of Thioflavin-T to monitor anti-fibrillogenic activity
Eduardo Coelho-Cerqueira, Anderson S Pinheiro, Cristian Follmer
Biochemical and Biophysical Research Communications
|
December 29, 2018
Formation of large oligomers of DOPAL-modified α-synuclein is modulated by the oxidation of methionine residues located at C-terminal domain
Eduardo Coelho-Cerqueira, Camila de Araújo Correia Campos, Cristian Follmer
The FEBS Journal
|
December 9, 2023
Fibrillation of α-synuclein triggered by bacterial endotoxin and lipid vesicles is modulated by N-terminal acetylation and familial Parkinson's disease mutations
José Raphael Monteiro Neto, Vanderlei de Araújo Lima, Cristian Follmer
Open Biology
|
July 14, 2026
Removing the noise: endotoxin-free α-synuclein for accurate in vitro screening of fibrillation modulators
Julia Flor, Daniel Izecksohn, Daniel Grasseschi, et al.
Expert Review of Neurotherapeutics
|
April 5, 2023
Alpha-synuclein in Parkinson's disease: a villain or tragic hero? A critical view of the formation of α-synuclein aggregates induced by dopamine metabolites and viral infection
Phelippe Carmo-Gonçalves, Eduardo Coelho-Cerqueira, Vanderlei de Araujo Lima, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
ACS Chemical Neuroscience
|
November 27, 2020
Viral Infection-Induced Gut Dysbiosis, Neuroinflammation, and α-Synuclein Aggregation: Updates and Perspectives on COVID-19 and Neurodegenerative Disorders
Cristian Follmer
Phytochemistry
|
August 21, 2007
Insights into the role and structure of plant ureases
Cristian Follmer
Expert Review of Neurotherapeutics
|
May 24, 2014
Monoamine oxidase and α-synuclein as targets in Parkinson's disease therapy
Cristian Follmer
Archives of Biochemistry and Biophysics
|
February 1, 2005
Effect of chemical modification of histidines on the copper-induced oligomerization of jack bean urease (EC 3.5.1.5)
Cristian Follmer, Célia R Carlini
ACS Chemical Neuroscience
|
October 20, 2020
<i>In Vitro</i> Protective Action of Monomeric and Fibrillar α-Synuclein on Neuronal Cells Exposed to the Dopaminergic Toxins Salsolinol and DOPAL
Phelippe Carmo-Gonçalves, Luciana Romão, Cristian Follmer
Bioorganic & Medicinal Chemistry Letters
|
May 20, 2014
Pitfalls associated with the use of Thioflavin-T to monitor anti-fibrillogenic activity
Eduardo Coelho-Cerqueira, Anderson S Pinheiro, Cristian Follmer
Biochemical and Biophysical Research Communications
|
December 29, 2018
Formation of large oligomers of DOPAL-modified α-synuclein is modulated by the oxidation of methionine residues located at C-terminal domain
Eduardo Coelho-Cerqueira, Camila de Araújo Correia Campos, Cristian Follmer
The FEBS Journal
|
December 9, 2023
Fibrillation of α-synuclein triggered by bacterial endotoxin and lipid vesicles is modulated by N-terminal acetylation and familial Parkinson's disease mutations
José Raphael Monteiro Neto, Vanderlei de Araújo Lima, Cristian Follmer
Open Biology
|
July 14, 2026
Removing the noise: endotoxin-free α-synuclein for accurate in vitro screening of fibrillation modulators
Julia Flor, Daniel Izecksohn, Daniel Grasseschi, et al.
Expert Review of Neurotherapeutics
|
April 5, 2023
Alpha-synuclein in Parkinson's disease: a villain or tragic hero? A critical view of the formation of α-synuclein aggregates induced by dopamine metabolites and viral infection
Phelippe Carmo-Gonçalves, Eduardo Coelho-Cerqueira, Vanderlei de Araujo Lima, et al.
Page
of 4